Molecule Details
InChIKeyLUZRJRNZXALNLM-JGRZULCMSA-N
Compound NameDihydroergotamine
Canonical SMILESCN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)20
Pfam Stratification Cross-Family
Avg pChEMBL7.59
SourceChEMBL
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB00320
Drug NameDihydroergotamine
CAS Number511-12-6
Groups approved
ATC Codes N02CA51 N02CA01
DescriptionA 9,10alpha-dihydro derivative of [ergotamine]. Dihydroergotamine is used as an abortive therapy for migraines.[L38469] Its use has largely been supplanted by triptans in current therapy due to the class's greater selectivity and more favourable side effect profile. Recent improvements have been mad...

Categories: Adrenergic Antagonists Adrenergic alpha-1 Receptor Antagonists Adrenergic alpha-Antagonists Agents that produce hypertension Alkaloids Analgesics Antidepressive Agents Antimigraine Preparations Cardiovascular Agents Central Nervous System Agents Central Nervous System Depressants Cytochrome P-450 CYP3A Inhibitors Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Inhibitors Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Dopamine Agents Dopamine Agonists Ergot Alkaloids and Derivatives Ergot-derivative Dopamine Receptor Agonists Ergotamine Derivative Ergotamines Heterocyclic Compounds, Fused-Ring Narrow Therapeutic Index Drugs Nervous System Neurotransmitter Agents P-glycoprotein inhibitors Peripheral Nervous System Agents Sensory System Agents Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome Serotonin 5-HT1 Receptor Agonists Serotonin 5-HT2 Receptor Agonists Serotonin Agents Serotonin Modulators Serotonin Receptor Agonists Sympatholytic (Adrenergic Blocking) Agents Vasoconstrictor Agents
Cross-references: BindingDB: 50295557 ChEBI: 4562 CHEMBL1732 ChemSpider: 10091 Drugs Product Database (DPD): 3359 C07798 D07837 PDB: 2GM PharmGKB: PA164743028 PubChem:10531 PubChem:46507711 RxCUI: 3418 Therapeutic Targets Database: DAP000078 Wikipedia: Dihydroergotamine ZINC: ZINC000003978005
Target Activities (20)
Target Gene Organism Category Pfam pChEMBL Type Source
P08913 ADRA2A Homo sapiens Human PF00001 9.0 Ki ChEMBL
P50406 HTR6 Homo sapiens Human PF00001 8.5 Ki ChEMBL
P18089 ADRA2B Homo sapiens Human PF00001 8.4 Ki ChEMBL
P41595 HTR2B Homo sapiens Human PF00001 8.4 Ki ChEMBL
P35462 DRD3 Homo sapiens Human PF00001 8.3 Ki ChEMBL
P28223 HTR2A Homo sapiens Human PF00001 8.1 Ki ChEMBL
P14416 DRD2 Homo sapiens Human PF00001 8.1 Ki ChEMBL
P18825 ADRA2C Homo sapiens Human PF00001 8.0 Ki ChEMBL
P25100 ADRA1D Homo sapiens Human PF00001 7.5 IC50 ChEMBL
P35348 ADRA1A Homo sapiens Human PF00001 7.5 Kd ChEMBL
P47898 HTR5A Homo sapiens Human PF00001 7.5 Ki ChEMBL
P21917 DRD4 Homo sapiens Human PF00001 7.5 Ki ChEMBL
P08908 HTR1A Homo sapiens Human PF00001 7.4 Ki ChEMBL
P35368 ADRA1B Homo sapiens Human PF00001 7.2 Kd ChEMBL
P34969 HTR7 Homo sapiens Human PF00001 7.2 Ki ChEMBL
P28335 HTR2C Homo sapiens Human PF00001 7.0 Ki ChEMBL
P28222 HTR1B Homo sapiens Human PF00001 7.0 Ki ChEMBL
P35372 OPRM1 Homo sapiens Human PF00001 6.8 Ki ChEMBL
Q99720 SIGMAR1 Homo sapiens Human PF04622 6.2 Ki ChEMBL
P28566 HTR1E Homo sapiens Human PF00001 6.2 Ki ChEMBL
DrugBank Target Actions (18)
Target Gene Target Name Action Type
P08684 CYP3A4 Cytochrome P450 3A4 inhibitor enzymes
P08684 CYP3A4 Cytochrome P450 3A4 substrate enzymes
P08908 HTR1A 5-hydroxytryptamine receptor 1A agonist targets
P08913 ADRA2A Alpha-2A adrenergic receptor agonist targets
P13945 ADRB3 Beta-3 adrenergic receptor agonist targets
P14416 DRD2 D(2) dopamine receptor agonist targets
P21917 DRD4 D(4) dopamine receptor agonist targets
P28221 HTR1D 5-hydroxytryptamine receptor 1D agonist targets
P28222 HTR1B 5-hydroxytryptamine receptor 1B agonist targets
P28223 HTR2A 5-hydroxytryptamine receptor 2A agonist targets
P28335 HTR2C 5-hydroxytryptamine receptor 2C agonist targets
P28566 HTR1E 5-hydroxytryptamine receptor 1E agonist targets
P30939 HTR1F 5-hydroxytryptamine receptor 1F agonist targets
P35348 ADRA1A Alpha-1 adrenergic receptors agonist targets
P35462 DRD3 D(3) dopamine receptor agonist targets
P41595 HTR2B 5-hydroxytryptamine receptor 2B agonist targets
Q13639 HTR4 5-hydroxytryptamine receptor 4 agonist targets
P08183 ABCB1 ATP-dependent translocase ABCB1 inhibitor transporters